Heart Disease News and Research

Latest Heart Disease News and Research

Studies advance the understanding of sensory disconnection during sleep and anesthesia

During sleep and under anesthesia, we rarely respond to such external stimuli as sounds even though our brains remain highly active.

28 May 2020

Is air pollution a risk factor for COVID-19 infection?

The COVID-19 pandemic began at the very end of 2019 in Wuhan city, Hubei province, China. However, its spread soon began to threaten the health of the whole country and then of the world, leading to nearly 5.7 million cases and over 355,000 dead as of today. A new study, published on the preprint server medRxiv* in May 2020, explores the effects of air pollution on COVID-19 infections in China.

27 May 2020

UTSW/Children's Health joint program approved as Certified Duchenne Care Center

A joint program of UT Southwestern Medical Center and Children's Health has been approved as a Certified Duchenne Care Center by Parent Project Muscular Dystrophy, the nation's most comprehensive nonprofit organization focused on finding a cure for Duchenne muscular dystrophy.

27 May 2020

City experts to develop a hybrid sensor for detection of diabetes

Dr Sumsun Naher and Professor Aziz Rahman have received a Marie Curie Fellowship to develop a hybrid sensor for the detection of diabetes from exhaled breath.

27 May 2020

ACE2 receptors in the kidney not linked to high BP or RAS blockers

Even as the COVID-19 pandemic continues to smolder and flare up in various parts of the world, researchers are still trying to make sense of the virus, its routes of spread, its target tissues, and the immune responses it induces. One crucial piece of knowledge is that the primary viral receptor is a human enzyme called angiotensin-converting enzyme 2 (ACE2).

27 May 2020

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

27 May 2020

Nimodipine-loaded biodegradable fibers to protect nerve cells after brain surgery

Brain surgery poses a major threat to nerve cells. Even slight injuries can kill the sensitive cells. The drug nimodipine could help prevent this.

27 May 2020

Study shows global prevalence of functional gastrointestinal disorders

For every ten adults in the world, four suffer from functional gastrointestinal disorders of varying severity. This is shown by a study of more than 73,000 people in 33 countries. University of Gothenburg scientists are among those now presenting these results.

27 May 2020

Smart e-glasses monitor person's brain waves and body movements, control video game

Fitness tracker bracelets and watches provide useful information, such as step count and heart rate, but they usually can't provide more detailed data about the wearer's health.

27 May 2020

Study highlights the benefits of palliative care for heart failure patients

Palliative care is valuable for heart failure patients, and, for those who are hospitalized, it can significantly lower the risk of repeated hospital admissions and the need for invasive procedures such as mechanical ventilation and defibrillator implantation, according to new research published today in the Journal of the American Heart Association, an open-access journal of the American Heart Association.

27 May 2020

Doxycycline is not effective in reducing the growth of abdominal aortic aneurysm

A new landmark study by researchers at the University of Maryland School of Medicine (UMSOM) found that patients with a vascular condition, called an abdominal aortic aneurysm, received no benefits from taking a common antibiotic drug to reduce inflammation.

27 May 2020

WHO halts Hydroxychloroquine in COVID-19 trial over safety concerns

The coronavirus disease (COVID-19) has taken a toll on 188 countries and territories across the globe. With the increasing number of confirmed cases, scientists race to develop treatments and vaccines to fight the novel coronavirus.

27 May 2020

Blood clotting disorders may explain some of the worst symptoms of COVID-19

The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.

27 May 2020

Meta-analysis of latest second-line treatments for status epilepticus

Status epilepticus (SE) is the most common neurologic emergency, with rates estimated between 1.3 and 81 cases per 100,000 people per year.

27 May 2020

What affects the case fatality rate of COVID-19? Analysis of top 50 affected countries

Ever since the beginning of the international spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 disease, researchers have been trying to identify the risk factors that increase the chances of infection. Now, a new study published on the preprint server medRxiv in May 2020 discusses various potential factors and reports the observed associations.

27 May 2020

Flickering of cardiac state could provide early warning for onset of atrial fibrillation

Affecting up to 4% of patients older than 65 years, atrial fibrillation ranks among the most common heart conditions. Described by health professionals as an "irregularly irregular" heart rhythm, episodes of atrial fibrillation continue to prove difficult to predict.

26 May 2020

UZH researchers develop new X-ray contrast agent for high-resolution vascular imaging

Various diseases in humans and animals - such as tumors, strokes or chronic kidney disease - damage the blood vessels. Capillaries, the smallest blood vessels in the body, are particularly affected.

26 May 2020

Study shows antihypertensive drugs do not raise serum levels of ACE2

A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).

26 May 2020

Montefiore and Einstein evaluate a new drug combination to fight COVID-19

Montefiore Health System Albert Einstein College of Medicine have begun the next stage of the Adaptive COVID-19 Treatment Trial (ACTT), to evaluate treatment options for people hospitalized with severe COVID-19 infection.

26 May 2020

New NIH grant will help Pennington Biomedical scientists to study metabolic diseases

A new federal grant will allow young scientists to delve into the mechanisms of emotional eating and preeclampsia and other disorders not considered "classic" metabolic diseases.

26 May 2020

Heart Disease News and Research

Latest Heart Disease News and Research

Studies advance the understanding of sensory disconnection during sleep and anesthesia

Is air pollution a risk factor for COVID-19 infection?

UTSW/Children's Health joint program approved as Certified Duchenne Care Center

City experts to develop a hybrid sensor for detection of diabetes

ACE2 receptors in the kidney not linked to high BP or RAS blockers

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

Nimodipine-loaded biodegradable fibers to protect nerve cells after brain surgery

Study shows global prevalence of functional gastrointestinal disorders

Smart e-glasses monitor person's brain waves and body movements, control video game

Study highlights the benefits of palliative care for heart failure patients

Doxycycline is not effective in reducing the growth of abdominal aortic aneurysm

WHO halts Hydroxychloroquine in COVID-19 trial over safety concerns

Blood clotting disorders may explain some of the worst symptoms of COVID-19

Meta-analysis of latest second-line treatments for status epilepticus

What affects the case fatality rate of COVID-19? Analysis of top 50 affected countries

Flickering of cardiac state could provide early warning for onset of atrial fibrillation

UZH researchers develop new X-ray contrast agent for high-resolution vascular imaging

Study shows antihypertensive drugs do not raise serum levels of ACE2

Montefiore and Einstein evaluate a new drug combination to fight COVID-19

New NIH grant will help Pennington Biomedical scientists to study metabolic diseases

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in